BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, Wahlstrom HE, Krom RA. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992;16:1290-9. [PMID: 1427667 [PMID: 1427667 DOI: 10.1002/hep.1840160527] [Cited by in Crossref: 96] [Cited by in F6Publishing: 70] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Michel B, Van Hout B, Bonsel G. 3 Assessing the benefits of transplant services. Baillière's Clinical Gastroenterology 1994;8:411-23. [DOI: 10.1016/0950-3528(94)90028-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
2 Klompmaker IJ, Haagsma EB, Verwer R, Jansen PLM, Slooff MJH. Primary Sclerosing Cholangitis and Liver Transplantation. Scandinavian Journal of Gastroenterology 2009;31:98-102. [DOI: 10.3109/00365529609094738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Olsson R, Broomé U, Danielsson A, Hägerstrand I, Järnerot G, Lööf L, Prytz H, Rydén BO, Wallerstedt S. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995;108:1199-203. [PMID: 7698589 DOI: 10.1016/0016-5085(95)90220-1] [Cited by in Crossref: 96] [Cited by in F6Publishing: 71] [Article Influence: 3.6] [Reference Citation Analysis]
4 Chung RT, Jaffe DL, Friedman LS. Complications of Chronic Liver Disease. Critical Care Clinics 1995;11:431-63. [DOI: 10.1016/s0749-0704(18)30075-7] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
5 Rosen HR, Shackleton CR, Martin P. INDICATIONS FOR AND TIMING OF LIVER TRANSPLANTATION. Medical Clinics of North America 1996;80:1069-102. [DOI: 10.1016/s0025-7125(05)70480-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
6 Salen G, Batta AK. BILE ACID ABNORMALITIES IN CHOLESTATIC LIVER DISEASES. Gastroenterology Clinics of North America 1999;28:173-93. [DOI: 10.1016/s0889-8553(05)70049-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Angulo P, Lindor KD. PRIMARY BILIARY CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS. Clinics in Liver Disease 1999;3:529-70. [DOI: 10.1016/s1089-3261(05)70084-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
8 Desch??nes M, Belle SH, Krom RA, Zetterman RK, Lake JR. EARLY ALLOGRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION: A Definition and Predictors of Outcome1. Transplantation 1998;66:302-10. [DOI: 10.1097/00007890-199808150-00005] [Cited by in Crossref: 175] [Cited by in F6Publishing: 155] [Article Influence: 7.3] [Reference Citation Analysis]
9 Pasha TM, Lindor KD. Diagnosis and therapy of cholestatic liver disease. Med Clin North Am 1996;80:995-1019. [PMID: 8804372 DOI: 10.1016/s0025-7125(05)70477-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Karnsakul W, Intihar P, Konewko R, Roy A, Colombani PM, Lau H, Schwarz KB. Living donor liver transplantation in children: A single North American center experience over two decades. Pediatr Transplant. 2012;16:486-495. [PMID: 22672018 DOI: 10.1111/j.1399-3046.2012.01725.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
11 Russo MW, Sandler RS, Mandelkehr L, Fair JH, Johnson MW, Brown RS. Payer status, but not race, affects the cost of liver transplantation. Liver Transpl 1998;4:370-7. [DOI: 10.1002/lt.500040510] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
12 Staufer K, Kivaranovic D, Rasoul-Rockenschaub S, Soliman T, Trauner M, Berlakovich G. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - Impact of changes in allocation policy. HPB (Oxford) 2018;20:916-24. [PMID: 29937419 DOI: 10.1016/j.hpb.2018.03.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Prytz H, Keiding S, Björnsson E, Broomé U, Almer S, Castedal M, Munk OL. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology. 2006;44:1572-1580. [PMID: 17133469 DOI: 10.1002/hep.21433] [Cited by in Crossref: 68] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
14 Brandsaeter B, Isoniemi H, Broomé U, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol. 2004;40:815-822. [PMID: 15094230 DOI: 10.1016/j.jhep.2004.01.002] [Cited by in Crossref: 153] [Cited by in F6Publishing: 117] [Article Influence: 8.5] [Reference Citation Analysis]
15 Leidenius M, Höckersted K, Broomé U, Ericzon BG, Friman S, Olausson M, Schrumpf E. Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. J Hepatol 2001;34:792-8. [PMID: 11451160 DOI: 10.1016/s0168-8278(01)00042-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology. 1999;29:365-370. [PMID: 9918911 DOI: 10.1002/hep.510290221] [Cited by in Crossref: 132] [Cited by in F6Publishing: 112] [Article Influence: 5.7] [Reference Citation Analysis]
17 Klein R, Pointner H, Zilly W, Glässner-Bittner B, Breuer N, Garbe W, Fintelmann V, Kalk JF, Müting D, Fischer R. Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver. 1997;17:119-128. [PMID: 9249725 DOI: 10.1111/j.1600-0676.1997.tb00793.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
18 Berlakovich GA, Imhof M, Karner-Hanusch J, Gotzinger P, Gollackner B, Gnant M, Hanelt S, Laufer G, Muhlbacher F, Steininger R. The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation. Transplantation. 1996;61:554-560. [PMID: 8610380 DOI: 10.1097/00007890-199602270-00007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
19 Noack KB, Speer T. Investigation of the patient with abnormal liver function tests. Baillieres Clin Gastroenterol 1997;11:83-95. [PMID: 9192062 DOI: 10.1016/s0950-3528(97)90055-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
20 Farges O, Malassagne B, Sebagh M, Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery. 1995;117:146-155. [PMID: 7846618 DOI: 10.1016/s0039-6060(05)80078-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
21 Kim WR, Dickson ER. PREDICTIVE MODELS OF NATURAL HISTORY IN PRIMARY BILIARY CIRRHOSIS. Clinics in Liver Disease 1998;2:313-31. [DOI: 10.1016/s1089-3261(05)70010-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Balan V, Larusso NF. HEPATOBILIARY DISEASE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 1995;24:647-69. [DOI: 10.1016/s0889-8553(21)00216-8] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
23 Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol. 2008;48 Suppl 1:S38-S57. [PMID: 18304683 DOI: 10.1016/j.jhep.2008.01.020] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 7.6] [Reference Citation Analysis]
24 Gossard AA. Diagnosis of Cholestasis. In: Carey EJ, Lindor KD, editors. Cholestatic Liver Disease. New York: Springer; 2014. pp. 1-12. [DOI: 10.1007/978-1-4939-1013-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Bambha K, Kim WR. Liver transplantation is effective, but is it cost-effective? Liver Transplantation;9:1308-11. [DOI: 10.1016/j.lts.2003.09.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
26 Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterology 1993;105:1865-76. [DOI: 10.1016/0016-5085(93)91086-w] [Cited by in Crossref: 73] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
27 Brown RS, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Liver Transpl 1998;4:170-6. [DOI: 10.1002/lt.500040211] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
28 Broomé U, Eriksson LS. Assessment for liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 1994;20:654-9. [PMID: 8071544 DOI: 10.1016/s0168-8278(05)80356-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Brandsæter B. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list. Liver Transplantation 2003;9:961-9. [DOI: 10.1053/jlts.2003.50169] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
30 Boyer TD, Kokenes DD, Hertzler G, Kutner MH, Michael Henderson J. Effect of distal splenorenal shunt on survival of patients with primary biliary cirrhosis. Hepatology 1994;20:1482-6. [DOI: 10.1002/hep.1840200617] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
31 Tekin K, Imber CJ, Atli M, Gunson BK, Bramhall SR, Mayer D, Buckels JA, McMaster P, Mirza DF. A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors. Transplantation. 2004;77:411-416. [PMID: 14966416 DOI: 10.1097/01.tp.0000110318.70879.20] [Cited by in Crossref: 50] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
32 Heneghan MA, O'Grady JG. Liver transplantation for malignant disease. Baillieres Best Pract Res Clin Gastroenterol 1999;13:575-91. [PMID: 10654921 DOI: 10.1053/bega.1999.0049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
33 Floreani A. Liver disorders in the elderly. Best Practice & Research Clinical Gastroenterology 2009;23:909-17. [DOI: 10.1016/j.bpg.2009.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
34 Talwalkar JA, Seaberg E, Kim WR, Wiesner RH. Predicting clinical and economic outcomes after liver transplantation using the mayo primary sclerosing cholangitis model and child-pugh score. Liver Transpl 2000;6:753-8. [DOI: 10.1053/jlts.2000.18485] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
35 Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994;20:829-838. [PMID: 7927223 DOI: 10.1002/hep.1840200410] [Cited by in Crossref: 418] [Cited by in F6Publishing: 371] [Article Influence: 14.9] [Reference Citation Analysis]
36 Kuo PC, Li K, Alfrey EJ, Jeffrey RB, Garcia G, Dafoe DC. Magnetic resonance imaging and hepatic hemodynamics: Correlation with metabolic function in liver transplantation candidates. Surgery 1995;117:373-9. [DOI: 10.1016/s0039-6060(05)80055-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
37 Gluck M, Cantone NR, Brandabur JJ, Patterson DJ, Bredfeldt JE, Kozarek RA. A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol. 2008;42:1032-1039. [PMID: 18580600 DOI: 10.1097/mcg.0b013e3181646713] [Cited by in Crossref: 86] [Cited by in F6Publishing: 23] [Article Influence: 6.1] [Reference Citation Analysis]
38 Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa TA, Tillery GW, Crippin JS, Klintmalm GB. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation. 1998;66:1300-1306. [PMID: 9846512 DOI: 10.1097/00007890-199811270-00006] [Cited by in Crossref: 114] [Cited by in F6Publishing: 86] [Article Influence: 4.8] [Reference Citation Analysis]
39 Yoshida EM, Lake JR. Selection of patients for liver transplantation in 1997 and beyond. Clin Liver Dis 1997;1:247-61, vii. [PMID: 15562567 DOI: 10.1016/s1089-3261(05)70269-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Ueno Y, Larusso NF. Primary sclerosing cholangitis. J Gastroenterol 1994;29:531-43. [DOI: 10.1007/bf02361256] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Sheila S. Primary biliary cirrhosis: Clarifying the issues. The American Journal of Medicine 1994;96:S27-33. [DOI: 10.1016/0002-9343(94)90187-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
42 Leonhardt S, Veltzke-Schlieker W, Adler A, Schott E, Eurich D, Faber W, Neuhaus P, Seehofer D. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases. Medicine (Baltimore) 2015;94:e2188. [PMID: 26656347 DOI: 10.1097/MD.0000000000002188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
43 Brown RS. Predicting outcome of transplantation for cholestatic liver disease: Child-pugh or mayo risk score? Liver Transpl 2000;6:759-61. [DOI: 10.1053/jlts.2000.19936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Kornasiewicz O, Lewandowski Z, Dudek K, Stankiewicz R, Nyckowski P, Krawczyk M. Prediction of graft loss and death in patients with primary sclerosing cholangitis. Transplant Proc. 2009;41:3110-3113. [PMID: 19857688 DOI: 10.1016/j.transproceed.2009.09.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
45 Johnson GK, Saeian K, Geenen JE. Primary sclerosing cholangitis treated by endoscopic biliary dilation: Review and long-term follow-up evaluation. Curr Gastroenterol Rep 2006;8:147-55. [DOI: 10.1007/s11894-006-0011-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
46 Bjøro K, Schrumpf E. Liver transplantation for primary sclerosing cholangitis. J Hepatol. 2004;40:570-577. [PMID: 15030971 DOI: 10.1016/j.jhep.2004.01.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
47 v. Schönfeld J. Primär sklerosierende Cholangitis (PSC): Diagnostik und Therapie. Med Klin 1999;94:445-6. [DOI: 10.1007/bf03044729] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
48 Neuberger J, Gunson B, Komolmit P, Davies MH, Christensen E. Pretransplant prediction of prognosis after liver transplantation in primary sclerosing cholangitis using a Cox regression model. Hepatology. 1999;29:1375-1379. [PMID: 10216118 DOI: 10.1002/hep.510290506] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
49 Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol. 1994;21:1061-1066. [PMID: 7699228 DOI: 10.1016/s0168-8278(05)80618-x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
50 Benhamou J. Indications for liver transplantation in primary biliary cirrhosis. Hepatology 1994;20:S11-3. [DOI: 10.1002/hep.1840200705] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
51 Keeffe E. Patient selection and listing policies for liver transplantation. Journal of Gastroenterology and Hepatology 2009;14:S42-7. [DOI: 10.1046/j.1440-1746.1999.01876.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
52 Brandsaeter B, Friman S, Broomé U, Isoniemi H, Olausson M, Bäckman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Höckerstedt K, Mäkisalo H, Kirkegaard P, Bjøro K. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol 2003;38:1176-83. [PMID: 14686722 DOI: 10.1080/00365520310006009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
53 Blachar A, Federle MP, Brancatelli G. Primary Biliary Cirrhosis: Clinical, Pathologic, and Helical CT Findings in 53 Patients. Radiology 2001;220:329-36. [DOI: 10.1148/radiology.220.2.r01au36329] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
54 van Milligen de Wit AW, van Bracht J, Rauws EA, Jones EA, Tytgat GN, Huibregtse K. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc. 1996;44:293-299. [PMID: 8885349 DOI: 10.1016/s0016-5107(96)70167-0] [Cited by in Crossref: 118] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
55 Wood RP, Ozaki CF, Katz SM, Johnston TD, Monsour HP, Dyer CH. Liver Transplantation: The Last Ten Years. Surgical Clinics of North America 1994;74:1133-54. [DOI: 10.1016/s0039-6109(16)46437-6] [Cited by in Crossref: 21] [Article Influence: 0.8] [Reference Citation Analysis]
56 Di Leo V, Venturi C, Baragiotta A, Martines D, Floreani A. Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2003;15:967-973. [PMID: 12923368 DOI: 10.1097/00042737-200309000-00005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
57 Bergasa NV. An approach to the management of the pruritus of cholestasis. Clinics in Liver Disease 2004;8:55-66. [DOI: 10.1016/s1089-3261(03)00128-4] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
58 Klein R, Berg PA. Significance of antimitochondrial antibody profiles in primary biliary cirrhosis. In: Lindor KD, Heathcote EJ, Poupon R, editors. Primary Biliary Cirrhosis. Dordrecht: Springer Netherlands; 1998. pp. 24-34. [DOI: 10.1007/978-94-011-4884-9_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
59 Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
60 Nyckowski P, Zieniewicz K, Pawlak J, Michałowicz B, Grzelak I, Patkowski W, Wróblewski T, Małkowski P, Paluszkiewicz R, Alsharabi A, Skwarek A, Pszenny C, Smoter P, Dudek K, Leowska E, Kosiński C, Paczkowska A, Gelo R, Andruszkiewicz P, Ziółkowski J, Ołdakowska U, Pączek L, Andrzejewska M, Pacho R, Rowiński O, Habior A, Butruk E, Szczerbań J, Krawczyk M. Liver transplantation in patients with hepatic failure. Transplantation Proceedings 2002;34:631-4. [DOI: 10.1016/s0041-1345(01)02870-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Terg R, Coronel E, Sordá J, Muñoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002;37:717-22. [PMID: 12445410 DOI: 10.1016/s0168-8278(02)00318-5] [Cited by in Crossref: 113] [Cited by in F6Publishing: 22] [Article Influence: 5.9] [Reference Citation Analysis]
62 Cole CR, Bucuvalas JC, Hornung R, Ryckman FC, Alonso MP, Balistreri WF, Kotagal U. Outcome after pediatric liver transplantation impact of living donor transplantation on cost. J Pediatr 2004;144:729-35. [PMID: 15192617 DOI: 10.1016/j.jpeds.2004.03.032] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Lake JR. CHANGING INDICATIONS FOR LIVER TRANSPLANTATION. Gastroenterology Clinics of North America 1993;22:213-29. [DOI: 10.1016/s0889-8553(21)00063-7] [Cited by in Crossref: 29] [Article Influence: 1.0] [Reference Citation Analysis]
64 Morimoto T, Honda G, Kawai Y, Hirose T, Nishio T, Shinkura N, Iimuro Y, Yamamoto N, Yamamoto Y, Ikai I, Shimahara Y, Yamaoka Y. Right hepatic lobectomy for hepatocellular carcinoma which developed in primary biliary cirrhosis: Report of a case. Surg Today 1999;29:646-50. [DOI: 10.1007/bf02482993] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
65 Neuberger J. Primary biliary cirrhosis. Lancet. 1997;350:875-879. [PMID: 9310614 DOI: 10.1016/s0140-6736(97)05419-6] [Cited by in Crossref: 135] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
66 Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, Dahlerup JF. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998;28:700-6. [PMID: 9731562 DOI: 10.1002/hep.510280316] [Cited by in Crossref: 141] [Cited by in F6Publishing: 96] [Article Influence: 5.9] [Reference Citation Analysis]
67 Schutz SM, Stevenson W, Shabib SM, Al-Hemsi B, Al-Rezeig M. An overview of orthotopic liver transplantation. Ann Saudi Med 1995;15:60-6. [PMID: 17587901 DOI: 10.5144/0256-4947.1995.60] [Reference Citation Analysis]
68 Mattalia A, Lüttig B, Rosina F, Leung PS, Van de Water J, Bauducci M, Ciancio A, Böker KH, Worman H, Cooper RL, Manns M, Ansari A, Rizzetto M, Gershwin M. Persistence of Autoantibodies against Recombinant Mitochondrial and Nuclear Pore Proteins after Orthotopic Liver Transplantation for Primary Biliary Cirrhosis. Journal of Autoimmunity 1997;10:491-7. [DOI: 10.1006/jaut.1997.0156] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
69 Jones DE, James OF, Bassendine MF. PRIMARY BILIARY CIRRHOSIS. Clinics in Liver Disease 1998;2:265-82. [DOI: 10.1016/s1089-3261(05)70007-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
70 Gholson CF, Mcdonald J, Mcmillan R. Liver transplantation: When is it indicated and what can be expected afterwards? Postgraduate Medicine 2017;97:101-14. [DOI: 10.1080/00325481.1995.11945961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Walker S, Theilmann L. Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. Journal of Hepatology 1997;26:560-6. [DOI: 10.1016/s0168-8278(97)80421-7] [Cited by in Crossref: 126] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
72 Knechtle SJ, D'alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995;118:615-20. [DOI: 10.1016/s0039-6060(05)80026-1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
73 Wiesner RH. Liver Transplantation for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: Predicting Outcomes With Natural History Models. Mayo Clinic Proceedings 1998;73:575-88. [DOI: 10.4065/73.6.575] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]